Product
NVX-CoV2705
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase 3 Open-Label, Single-Arm Study to Evaluate the Safety and Immunogenicity of a JN.1 Subvariant SARS CoV-2 rS VaccineStatus: Not yet recruiting, Estimated PCD: 2025-02-15